Study guide
13.3 Musculoskeletal and Integumentary Effects
Certified Pediatric Hematology Oncology Nurse CPHON®
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Eligibility, Application, and Testing Logistics 1.3 Test Content Outline and Study Strategy
2 Care Continuum
2.1 Transition of Care: Primary Care and Levels of Care 2.2 End-of-Life Care 2.3 Health Promotion and Maintenance 2.4 Survivorship
3 Leukemias and Lymphomas
3.1 Acute Lymphoblastic Leukemia 3.2 Acute Myeloid Leukemia and Related Myeloid Disease 3.3 Hodgkin and Non-Hodgkin Lymphomas
4 CNS, Neuroblastoma, and Renal Tumors
4.1 Central Nervous System Tumors 4.2 Neuroblastoma 4.3 Wilms Tumor and Other Renal Tumors
5 Sarcomas and Other Solid Tumors
5.1 Osteosarcoma and Ewing Sarcoma 5.2 Rhabdomyosarcoma and Soft-Tissue Sarcomas 5.3 Retinoblastoma, Hepatoblastoma, and Germ Cell Tumors
6 Hematologic Disorders
6.1 Sickle Cell Disease 6.2 Thalassemia and Other Hemoglobinopathies 6.3 Hemophilia, von Willebrand Disease, and Coagulopathies 6.4 Immune Thrombocytopenia, Aplastic Anemia, and Bone Marrow Failure
7 Pathophysiology, Genetics, and Diagnostics
7.1 Anatomy, Physiology, and Pathophysiology Foundations 7.2 Genetics and Genomics 7.3 Diagnostic Testing, Staging, and Prognosis
8 Clinical Trials and Professional Performance
8.1 Clinical Trials and Informed Consent 8.2 Scope, Standards, and Regulatory Practice 8.3 Ethics and Patient-Family Education
9 Chemotherapy and Biotherapy
9.1 Chemotherapy Principles, Classes, and Pediatric Protocols 9.2 Safe Handling, Administration, and Vesicant Precautions 9.3 Biotherapy
10 Immunotherapy, Cellular Therapy, and Radiation
10.1 Immunotherapy 10.2 Cellular Therapies including CAR-T 10.3 Radiation Therapy, I-131-MIBG, and Proton Beam
11 HSCT, Surgery, Transfusion, and Coagulation Therapy
11.1 Hematopoietic Stem Cell Transplantation 11.2 Surgical Management 11.3 Blood Product Therapy, Leukapheresis, and Coagulation Therapy
12 Neurologic, Respiratory, and Cardiovascular Effects
12.1 Neurological Acute, Chronic, and Late Effects 12.2 Respiratory and Lymphatic Effects 12.3 Cardiovascular Effects
13 Gastrointestinal, Renal, Musculoskeletal, and Integumentary Effects
13.1 Gastrointestinal Effects 13.2 Renal and Genitourinary Effects 13.3 Musculoskeletal and Integumentary Effects
14 Endocrine, Hematologic, Immunologic, and Sensory Effects
14.1 Endocrine and Reproductive Effects 14.2 Hematological and Immunological Effects 14.3 Ophthalmological and Otological Effects
15 Pain, Sleep, Fatigue, and Mental Health
15.1 Pain Assessment and Management 15.2 Sleep Disturbance and Fatigue 15.3 Mental Health Effects
16 Supportive Care
16.1 Medical Devices: Venous Access, Pumps, Shunts, and Tubes 16.2 Blood Product Administration 16.3 Colony-Stimulating Factors 16.4 Interdisciplinary, Palliative, and Complementary Care
17 Infectious and Gastrointestinal Emergencies
17.1 Sepsis 17.2 Typhlitis 17.3 Pancreatitis and Bowel Obstruction
18 Metabolic Emergencies
18.1 Diabetes Insipidus and SIADH 18.2 Tumor Lysis Syndrome 18.3 Cytokine Release Syndrome
19 DIC, Hyperleukocytosis, and Sinusoidal Obstructive Syndrome
19.1 Disseminated Intravascular Coagulation and Hemorrhage 19.2 Hyperleukocytosis 19.3 Sinusoidal Obstructive Syndrome (Veno-Occlusive Disease)
20 Sickle Cell and Hemostasis Emergencies
20.1 Splenic Sequestration 20.2 Vaso-Occlusive Crisis 20.3 Stroke, Thrombosis, and Joint Bleed
21 Cardiopulmonary Emergencies
21.1 Acute Chest Syndrome 21.2 Respiratory Distress and Mediastinal Mass 21.3 Pleural Effusions and Arrhythmias
22 Neurologic and Infusion Emergencies
22.1 Increased Intracranial Pressure 22.2 Seizures and PRES 22.3 Spinal Cord Compression 22.4 Hypersensitivity Reactions and Extravasation
23 Family, Caregivers, and Social Integration
23.1 Effects of Acute and Chronic Illness on Patient and Family 23.2 Patient and Family/Caregiver Support 23.3 Integration into Family, School, Work, Camp, and Social Environment
24 Development, Grief, Culture, and Community Resources
24.1 Principles of Growth and Development 24.2 Grief and Bereavement 24.3 Culture, Sexuality and Gender, Socioeconomics, and Community Resources
13.3 Musculoskeletal and Integumentary Effects
Key Takeaways Explain This Topic AI
Steroid myopathy is proximal weakness on dexamethasone or prednisone; do not stop corticosteroids abruptly, and use fall precautions together with vincristine neuropathy.
AVN of hips and knees is a steroid late effect—image limp and weight-bearing pain rather than calling it growing pains. Methotrexate osteopathy is bone pain and fracture risk on long-term or high-dose exposure.
Amputation and limb-salvage rehab, phantom pain, and prosthesis precautions are the post-sarcoma plan. Radiation across a growth plate can arrest that physis and produce limb-length discrepancy years later.
Skin maps include radiation dermatitis, GVHD rash (palms, soles, ears), hand-foot syndrome, steroid acne, photosensitivity, and nail changes. EGFR inhibitor rash is rare in pediatrics.
Petechiae from thrombocytopenia are not ecthyma gangrenosum—a necrotic lesion in a neutropenic child is an infectious emergency. Protect wounds, graft sites, central-line dressing skin, and pressure surfaces in immobile children.
Last updated: August 2026
TCO IV.A.6 and IV.A.7 test musculoskeletal and integumentary acute, chronic, and late effects. Bones, joints, muscle, growth plates, skin, nails, wounds, and central-line dressing sites are the organs. This is not the surgical-staging chapter and not the full GVHD grading lecture. Here the nurse keeps a steroid-weak child from falling, names avascular necrosis (AVN) instead of "growing pains," and does not call every purple spot a bruise when ecthyma gangrenosum is on the differential.
A 6-year-old on dexamethasone who cannot rise from the toilet, a 15-year-old after osteosarcoma limb salvage who will not bear weight, and a neutropenic toddler with a black necrotic skin lesion are the pictures.
Muscle, bone, joints, and growth
Steroid myopathy is proximal weakness from dexamethasone or prednisone . Dexamethasone is often harsher. The child cannot climb stairs, rise from the floor, or get off the toilet without using the arms (a pediatric Gower-like pattern). Mood lability travels with the same drug. Involve physical therapy, pad falls, do not force competitive physical education, and do not stop corticosteroids abruptly —adrenal insufficiency is an endocrine trap. Weakness that is distal, asymmetric, or accompanied by foot drop is more vincristine neuropathy than steroid myopathy; both cause falls .
AVN (osteonecrosis) of the hips and knees is a steroid late effect, especially in adolescents on acute lymphoblastic leukemia pathways. Pain with weight bearing, a limp, and limited internal rotation are not "attention-seeking after clinic." Imaging as ordered (often magnetic resonance imaging) belongs early. Activity modification, pain control, and orthopedic referral follow. Do not tell a 16-year-old that AVN will "grow out" because steroids have stopped.
Methotrexate osteopathy is bone pain, osteopenia, and sometimes fractures during long-term or high-dose methotrexate exposure. It is not automatically AVN and not automatically vincristine pain. Report new bony point tenderness.
After amputation or limb-salvage reconstruction for osteosarcoma or Ewing sarcoma, rehabilitation is the treatment: residual-limb shaping, phantom-limb pain recognition, prosthesis or endoprosthesis precautions, and school re-entry that includes hall passes and no contact sport until orthopedics clears. A child who will not look at the limb is not "noncompliant"; involve child life and physical and occupational therapy. Vincristine neuropathy on the remaining limb plus a new prosthesis is a fall disaster—teach night lights, non-skid socks, and an ankle-foot orthosis when foot drop appears.
Radiation across a growth plate (physis) can arrest that plate and produce limb-length discrepancy , scoliosis, or hypoplasia of the irradiated field years later. Young age raises risk. Survivorship measurement of leg lengths and a shoe lift are nursing and orthopedic business, not a surprise at a 10-year reunion. Do not invent a single gray threshold as ONCC fact; teach field, age, and surveillance.
Skin, nails, wounds, and line sites
Radiation dermatitis ranges from erythema and dry desquamation to moist desquamation in the beam. Keep skin clean, use protocol moisturizers, avoid extra adhesive, alcohol, and heating pads in the field, and protect from sun. Do not scrape peel; moist areas need a wound plan, not powder from home.
Acute GVHD rash after allogeneic HSCT is often maculopapular and likes palms, soles, and ears . Chronic GVHD can be lichenoid or sclerodermatous. Photograph, grade as the transplant team directs, and do not start a new lotion that masks the exam. Chemotherapy rashes vary; epidermal growth factor receptor (EGFR) inhibitor papulopustular rash is an adult pattern that is rare in pediatrics —mention it so you do not import adult drug lists as CPHON default.
Hand-foot syndrome (palmar-plantar erythrodysesthesia) from selected agents (high-dose cytarabine in some children; other protocol drugs) is painful erythema, swelling, and blistering of palms and soles. Pain control, cooling, and holding or reducing the drug as ordered beat another alcohol-based sanitizer marathon. Steroid acne is facial and truncal pustules on dexamethasone or prednisone; it is not necessarily infection, but superinfection happens—do not pick.
Petechiae from thrombocytopenia are pinpoint, non-blanching, often pressure-site or dependent. They are not ecthyma gangrenosum , which is a necrotic, often black lesion in a neutropenic child and is Pseudomonas (or other gram-negative) until proven otherwise—an infectious emergency, not a "watch the bruise" note. Fever plus a new necrotic skin lesion is a same-hour workup.
Photosensitivity follows selected agents (including some methotrexate and other protocol drugs) and radiation: teach sun protection, hats, and that "a little sun for vitamin D" is not the plan during photosensitizing therapy. Nail changes —lines, pigmentation, onycholysis, or paronychia—follow many cytotoxics; keep nails short and report painful nail-fold infection in neutropenia.
Wound healing fails when the child is neutropenic or malnourished. Surgical incisions, biopsy sites, graft harvest sites (autologous skin or bone grafts, HSCT harvest sites), and central-line dressing skin all need a sterile, adhesive-minimizing plan. Do not change a stable central-line dressing daily "just because," and do not ignore a red tunnel. Pressure injury in immobile children—steroid myopathy, vincristine neuropathy, postoperative bone-sarcoma, or mucositis pain that keeps a child in one position—is preventable with turning, surfaces, and nutrition. A stageable pressure injury on a 7-year-old is a nursing quality event, not "kids don't get bedsores."
The CPHON product is a child who is not falling on dexamethasone, whose hip pain is imaged rather than dismissed, whose necrotic skin lesion is treated as infection, and whose radiation field and line dressing are protected rather than decorated with home adhesive.
- Effect Trigger Nursing focus
- Steroid myopathy Dexamethasone, prednisone Proximal weakness, PT, no abrupt stop
- AVN Steroids; hips and knees Weight-bearing pain, imaging, orthopedics
- MTX osteopathy Long-term or HD methotrexate Bone pain, fracture risk
- Limb salvage / amputation Bone sarcoma surgery Rehab, phantom pain, prosthesis
- Vincristine neuropathy Vinca Falls, AFO, bowel overlap
- Growth-plate arrest RT across physis Limb-length discrepancy surveillance
- Radiation dermatitis Beam Skin care; no extra irritants
- GVHD rash Allo HSCT Palms, soles, ears; photograph
- Hand-foot / steroid acne Selected chemo; steroids Pain, blister care; do not pick acne
- Ecthyma gangrenosum Pseudomonas in neutropenia Not ordinary petechiae; emergency
- Pressure injury / line skin Immobility; dressings Turn, nutrition, adhesive-minimizing care
Loading diagram... Musculoskeletal and integumentary map: falls, AVN, skin emergencies
Teaching emphasis: musculoskeletal and skin findings that must not be dismissed (relative emphasis, not incidence)